BRPI0606169A2 - preparo de rosuvastatina - Google Patents

preparo de rosuvastatina

Info

Publication number
BRPI0606169A2
BRPI0606169A2 BRPI0606169-9A BRPI0606169A BRPI0606169A2 BR PI0606169 A2 BRPI0606169 A2 BR PI0606169A2 BR PI0606169 A BRPI0606169 A BR PI0606169A BR PI0606169 A2 BRPI0606169 A2 BR PI0606169A2
Authority
BR
Brazil
Prior art keywords
rosuvastatin
preparation
rosuvastatin preparation
processes
intermediates
Prior art date
Application number
BRPI0606169-9A
Other languages
English (en)
Inventor
Anna Balanov
Valerie Niddam-Hildesheim
Natalia Shenkar
Original Assignee
Teva Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/360,725 external-priority patent/US20070037979A1/en
Application filed by Teva Pharma Ltd filed Critical Teva Pharma Ltd
Publication of BRPI0606169A2 publication Critical patent/BRPI0606169A2/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PREPARO DE ROSUVASTATINA. São fornecidos processos para o preparo de intermediários de rosuvastatina e seu uso no preparo de rosuvastatina e sais da rosuvastatina.
BRPI0606169-9A 2005-10-04 2006-10-04 preparo de rosuvastatina BRPI0606169A2 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US72387505P 2005-10-04 2005-10-04
US73297905P 2005-11-02 2005-11-02
US75107905P 2005-12-15 2005-12-15
US76050606P 2006-01-19 2006-01-19
US76234806P 2006-01-25 2006-01-25
US11/360,725 US20070037979A1 (en) 2005-02-22 2006-02-22 Preparation of rosuvastatin
PCT/US2006/038921 WO2007041666A1 (en) 2005-10-04 2006-10-04 Preparation of rosuvastatin

Publications (1)

Publication Number Publication Date
BRPI0606169A2 true BRPI0606169A2 (pt) 2009-06-02

Family

ID=39595929

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606169-9A BRPI0606169A2 (pt) 2005-10-04 2006-10-04 preparo de rosuvastatina

Country Status (5)

Country Link
JP (1) JP2008521836A (pt)
BR (1) BRPI0606169A2 (pt)
CA (1) CA2625290A1 (pt)
IL (1) IL187948A0 (pt)
MX (1) MX2007006647A (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090018964A (ko) * 2007-04-18 2009-02-24 테바 파마슈티컬 인더스트리즈 리미티드 Ｈｍｇ-ｃｏａ 환원 효소 억제제의 중간체의 제조 방법
WO2015008294A1 (en) * 2013-07-16 2015-01-22 Suven Life Sciences Limited Process for the preparation of rosuvastatin calcium and preparation of its novel intermediates
WO2015119261A1 (ja) * 2014-02-06 2015-08-13 株式会社エーピーアイ コーポレーション ロスバスタチンカルシウム及びその中間体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
JP3400038B2 (ja) * 1993-10-19 2003-04-28 塩野義製薬株式会社 ピリミジン誘導体の製造方法
KR100511533B1 (ko) * 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
CN1742000A (zh) * 2002-12-10 2006-03-01 兰贝克赛实验室有限公司 制备若舒伐他汀的方法

Also Published As

Publication number Publication date
IL187948A0 (en) 2008-03-20
CA2625290A1 (en) 2007-04-12
JP2008521836A (ja) 2008-06-26
MX2007006647A (es) 2007-07-25

Similar Documents

Publication Publication Date Title
TW200640878A (en) Preparation of rosuvastatin
BRPI0809583A2 (pt) polipeptídeos fgf-21 modificados e seus usos
UY32649A (es) "sales de 4-(dimetilamino)butil 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil)acetato"
BRPI0924183A2 (pt) inibidores de proteína quinase, formas cristalinas, formulações farmacêuticas e uso
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0814267A2 (pt) Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
EA201200550A1 (ru) Фармацевтические композиции, включающие bi-1356 и метформин
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0507118A (pt) polipeptìdeos de interferon humano modificado e seus usos
BRPI0916829A2 (pt) axmi-115, axmi-113, axmi-005, axmi-13 e axmi-184; proteínas inseticidas e metódos para seu uso.
UY32203A (es) Amino pirimidinas y su uso en terapia
CL2006001266A1 (es) Formas solidas cristalinas i, ii, iii, iv y v de tigeciclina; procedimiento de preparacion de las formas cristalinas ii, iv y v; composicion farmaceutica que comprende las formas cristalinas; y su uso para tratar infecciones bacterianas.
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
UY29853A1 (es) Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas-
BRPI0813237B8 (pt) composto, método para preparar o composto, medicamento, e, uso do composto
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
ATE417833T1 (de) Triazinderivate mit carbamatfunktion
BRPI0817542A2 (pt) NOVOS INIBIDORES DE sEH E SEU USO
BRPI0719345A2 (pt) Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.